|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 1/14 | |
| C07K 1/34 | |||
| C07K 14/61 |
| (11) | Number of the document | 1833841 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05826671.9 |
| Date of filing the European patent application | 2005-12-20 | |
| (97) | Date of publication of the European application | 2007-09-19 |
| (45) | Date of publication and mention of the grant of the patent | 2010-04-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2005/056976 |
| Date | 2005-12-20 |
| (87) | Number | WO 2006/069940 |
| Date | 2006-07-06 |
| (30) | Number | Date | Country code |
| 200402022 | 2004-12-29 | DK |
| (72) |
BECKER, Peter, DK
CHRISTENSEN, Thorkild, DK
|
| (73) |
Novo Nordisk Health Care AG,
Andreasstrasse 15, 8050 Zürich,
CH
|
| (54) | METHOD FOR PREVENTING FORMATION OF TRISULFIDE DERIVATIVES OF POLYPEPTIDES |
| METHOD FOR PREVENTING FORMATION OF TRISULFIDE DERIVATIVES OF POLYPEPTIDES |